Anti-arrhythmic peptide N-3-(4-hydroxyphenyl)propionyl Pro-Hyp-Gly-Ala-Gly-OH reduces dispersion of action potential duration during ischemia/reperfusion in rabbit hearts.

Abstract

During ischemia, cardiac gap junctions close and neighboring cells uncouple. This leads to slow conduction, increased dispersion of APD90 (duration from action potential beginning to 90% of repolarization), nonuniform anisotropy, and unidirectional conduction block, all of which favor the induction of reentry arrhythmias. It has been suggested that anti-arrhythmic peptides increase gap junction conductance during states of reduced coupling. The aim of this study was to test the effect of the anti-arrhythmic peptide N-3-(4-hydroxyphenyl)propionyl Pro-Hyp-Gly-Ala-Gly-OH (HP-5) (10(-10) ) on dispersion of epicardial APD90 during both normokalemic and hypokalemic ischemia/reperfusion in isolated perfused rabbit hearts. HP-5 did not affect average APD90, heart rate, left ventricular contractility (LVP dP/dtmax), or mean coronary flow. HP-5 significantly reduced the epicardial APD dispersion during hypokalemic ischemia (HP-5 treated: 24.1 +/- 3.4 ms, untreated: 33.9 +/- 3.1 ms, p < 0.05 versus untreated) and during normokalemic reperfusion but not during normokalemic ischemia or control conditions. In addition, among untreated hearts subjected to hypokalemic ischemia/reperfusion, seven of 10 developed ventricular fibrillation, whereas only three of nine hearts perfused with HP-5 developed ventricular fibrillation. These results show that HP-5 is able to reduce APD90 dispersion during hypokalemic ischemia in rabbit hearts.

• Authors: Anne Louise Kjølbye, Niels-Henrik Holstein-Rathlou, Jørgen Søberg Petersen
• Journal: Journal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 40 Issue 5 Pg. 770-9 (Nov 2002) ISSN: 0160-2446 [Print] United States
• PMID: 12409986 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Anti-Arrhythmia Agents
• alpha-Defensins
• neutrophil peptide 5

Topics

• Action Potentials (drug effects)
• Animals
• Anti-Arrhythmia Agents (therapeutic use)
• Electrocardiography
• Electrophysiology
• Heart (physiology)
• Hemodynamics (drug effects)
• Ischemia (drug therapy)
• Male
• Myocardial Contraction (drug effects)
• Rabbits
• alpha-Defensins (therapeutic use)